Home > Financial Ratios > DIVIS LABORATORIES

DIVIS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

DIVIS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 30.49-6.23-32.1036.7145.25

What is the latest Core EBITDA Growth ratio of DIVIS LABORATORIES ?

The latest Core EBITDA Growth ratio of DIVIS LABORATORIES is 30.49 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202530.49
Mar2024-6.23
Mar2023-32.10
Mar202236.71
Mar202145.25

How is Core EBITDA Growth of DIVIS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 30.49
Positive
Mar2024 -6.23
Negative
Mar2023 -32.1
Negative
Mar2022 36.71
-18.87
Mar2021 45.25 -

Other Financial Ratios of DIVIS LABORATORIES


Compare Core EBITDA Growth ratio of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹171,786.5 Cr 2.8% 7.2% 7.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,185.0 Cr 3.5% 12.3% 5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,923.0 Cr 3.8% 12.1% 42.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,081.0 Cr 3% 9.1% 11.6% Stock Analytics
CIPLA ₹109,680.0 Cr 1.2% 2.8% -9.1% Stock Analytics
MANKIND PHARMA ₹94,121.6 Cr 12.5% 8.5% -8.2% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

2.8%

7.2%

7.1%

SENSEX

-0.3%

-0.1%

8.3%


You may also like the below Video Courses